Continuous Hemodialysis With an Enhanced Middle Molecule Clearance Membrane

NCT01067313 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Fresenius Medical Care France

Collaborators